Trending Topic

Breast Cancer
29 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Endocrine therapy (ET) has changed the natural history of hormone receptor-positive (HR+) breast cancer (BC) and is the cornerstone of the treatment of HR+ BC. There are several ETs approved for the treatment of BC, including selective oestrogen receptor modulators (SERMs; tamoxifen), aromatase inhibitors (AIs; anastrazole, letrozole and exemestane) and selective oestrogen receptor degraders (SERDs; fulvestrant […]

Call for Submissions 2018

Axel S Merseburger
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Dec 12th 2017 European Oncology & Haematology, 2017;13(2):101 DOI: https://doi.org/10.17925/EOH.2017.13.02.101
Select a Section…
1

Article

Dear Colleagues,

European Oncology & Haematology is now accepting submissions to the Summer and Winter 2018 editions. European Oncology & Haematology aims to publish topical articles, which are chosen for their evaluation of current practices and research that directly affect practitioners in the fields of oncology and haematology.

Authors are invited to submit original research, review articles, case reports and editorials across all aspects of oncology and haematology. We are particularly interested in real-world studies and review articles that give a concise overview of the latest clinical trial data and developments, illuminate clinical practice and are of interest to practising oncologists and haematologists. Authors can submit their manuscript directly through the Editorial Manager site (details below) and presubmission enquiries can be made to the journal’s editor (helen.fowler@touchmedicalmedia.com).

European Oncology & Haematology is an open access journal, which means that your paper is directly available to anyone in the world to download and read for free. Submitted articles undergo a thorough peer review process to ensure scientific and ethical integrity, and accepted articles are published both in print and online. We also encourage authors to submit accompanying multimedia content alongside their article.

We look forward to working with you.

Axel S Merseburger and the European Oncology & Haematology team

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup